Optimized bedside brain monitoring for newborns and infants in intensive care
Official title: Critical Care Optimized Pediatric Quantitative EEG
Run by Nantes University Hospital · NCT06726408 · Data updated 2026-11-12
This project will try adding extra EEG electrodes and automated analysis to bedside monitoring to better find seizures and other brain problems in babies and children under 2 in intensive care.
Quick facts
| Study type | Observational |
|---|---|
| Ages | Any age to 24 Months |
| Sex | All |
| Enrollment | 120 (estimated) |
| Sponsor | Nantes University Hospital Academic / other |
| Locations | 1 site (Nantes) |
| Status | Recruiting |
| Started | September 16, 2025 |
| Main results expected | September 16, 2027 |
| Study ends | September 16, 2027 |
| Registry record updated | March 10, 2026 |
| Trial ID | NCT06726408 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Infants and young children under 2 years old admitted to the intensive care unit who require neuromonitoring, whose legal representatives consent and are French‑speaking, and who are covered by social security are eligible.
✕Probably not a fit
Preterm infants with corrected age under 37 weeks, patients who cannot have electrodes placed (for example after neurosurgery), and those whose families cannot consent in French are excluded and unlikely to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The project configures an 8‑channel aEEG display with complementary displays (CDSA) and automated seizure detection, and expands bedside monitoring to a 10‑electrode montage. Teams will be trained on electrode placement and the use of reading aids, then patients under age 2 in the ICU who need neuromonitoring will be enrolled for continuous bedside recording. Clinical interpretations at the bedside will be available in real time and a neurophysiologist can provide on‑demand readings during office hours. All full EEG recordings will undergo blinded post‑hoc review by a pediatric EEG expert as the gold standard to determine how well the optimized quantitative tools detect seizures and encephalopathy.
Why it matters
Potential benefit: If successful, this approach could detect more seizures sooner and help clinicians start treatments that may improve neurological outcomes for critically ill infants.
How similar studies have gone: Prior work shows continuous EEG is the gold standard and amplitude‑integrated EEG has modest seizure detection, but combining an expanded electrode montage with automated detection and targeted neurophysiology input is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria : * Patients younger than 2 years old hospitalized in the intensive care unit with an indication for neuromonitoring. The same patient may be included multiple times. * Written non-opposition from legal representatives. * Patients affiliated with or beneficiaries of a social security or similar scheme (CMU). Exclusion Criteria : * Parents who do not understand French. * Inability to set up monitoring equipment (neurosurgery preventing access to electrode placement sites). * Corrected age \< 37 weeks of gestation (GA) for preterm infants.
Where it's running
-
CHU de Nantes
Nantes, France Recruiting
Study contacts
- Study coordinator: Noura ZAYAT, PH
- Email: noura.zayat@chu-nantes.fr
- Phone: 33 2 76 64 37 91
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Gentle Touch and Sensory Changes to Ease Heel Pricks in Preterm Babies
This study tests whether gentle human touch or a quiet, reduced-stimulation environment can reduce pain and improve comfort during heel blood collection for premature infants.
-
Pasteurised donor human milk for term babies born to mothers with diabetes
This trial will try giving pasteurised donor human milk instead of formula to term infants of mothers with diabetes during the first five days to see if it reduces neonatal unit admissions for low blood sugar.
-
Music in the NICU: TÜMATA and Mozart to help newborns sleep and feel comfy
This trial tests whether TÜMATA or Mozart music helps newborns in the NICU sleep longer and feel more comfortable compared with routine care.
-
Community-partnered doula support for NICU families
This study will test whether pairing parents of NICU infants with a community doula for six weeks reduces parental stress compared with usual care.
-
Genomic changes of Klebsiella pneumoniae and Enterobacter cloacae in ICU patients over time
This study tests how the gut bacteria Klebsiella pneumoniae and Enterobacter cloacae evolve over time in adults in ICUs.
-
Using blood cell ratios and procalcitonin to predict outcomes for adults with sepsis in the ICU
This project will test whether routine blood measures—neutrophil-to-lymphocyte-and-platelet ratio, procalcitonin, and total white blood cell count—can help predict outcomes for adults with sepsis in the intensive care unit.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.